Clinical Trial Update: Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating melatonin as a neuroprotectant in preterm infants has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Premature Birth

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Imperial College London | Conditions: Premature Birth, Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28